AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study
Top Cited Papers
Open Access
- 1 November 2004
- journal article
- clinical trial
- Published by Elsevier in Molecular Therapy
- Vol. 10 (5) , 967-972
- https://doi.org/10.1016/j.ymthe.2004.08.002
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma modelCancer Gene Therapy, 2002
- Thymidine Kinase Gene Therapy for Human Malignant Glioma, Using Replication-Deficient Retroviruses or AdenovirusesHuman Gene Therapy, 2000
- Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: Effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactionsCancer Gene Therapy, 2000
- 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosisNature Medicine, 1999
- A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent GlioblastomaHuman Gene Therapy, 1998
- β-Galactosidase Gene Transfer to Human Malignant Glioma In Vivo Using Replication-Deficient Retroviruses and AdenovirusesHuman Gene Therapy, 1998
- Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cellsNature Medicine, 1997
- Adenovirus‐mediated gene therapy of experimental gliomasJournal of Neuroscience Research, 1994
- Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Proceedings of the National Academy of Sciences, 1994
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992